Circle Cardiovascular Imaging Announces Partnership with DiA Imaging Analysis

Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. have announced a multi-year partnership that leverages the companies’ synergies in cardiac AI and data analytics.

As a global leader in cardiovascular imaging reading and reporting for Cardiac MR and Cardiac CT, the company has now expanded its rich product offering to a complete cardiovascular imaging portfolio, with the addition of DiA’s FDA-cleared and CE-marked LVivo™ Toolbox – a line of innovative AI-based cardiac ultrasound solutions. This collaboration will deliver expanded state-of-the-art multi-modality imaging solutions to Circle Cardiovascular Imaging’s  customers, while providing new opportunities for physicians, patients, and hospitals worldwide.

“By adding DiA’s solutions, Circle Cardiovascular Imaging is broadening its extensive portfolio of cardiovascular MR and CT, to include ultrasound imaging functionality, offerings that are unparalleled in the market,” said Greg Ogrodnick, CEO of Circle Cardiovascular Imaging.

The company will offer its customers DiA’s LVivo Toolbox, as set of cardiac ultrasound AI solutions which will include LVivo Seamless™ – a unique system that runs “behind the scenes,” automatically selecting the optimal cardiac ultrasound views and generating automated quantifications and indications of both left and right ventricles. The system then immediately extracts these results to the echo reports.

The solutions of both companies are vendor-neutral, running on any scanner, and they can easily integrate into hospital and enterprise sites, with deployments that work with any IT infrastructure.

“Joining forces with Circle Cardiovascular Imaging will accelerate our mission to rapidly deploy health providers with our most advanced and most accurate cardiac ultrasound AI solutions, which will simplify workflows and improve patient outcomes,” said Hila Goldman-Aslan, CEO of DiA Imaging Analysis.

DiA will spotlight its AI-enabled solutions across its imaging portfolio at the upcoming American Society of Echocardiography (ASE) 2021 virtual event (June 18-21, 2021).

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.